Skip to main content

Table 2 Association of precancerous conditions, abnormal gastric biopsy, atrophy, metaplasia and dysplasia with demographic and clinical characteristics of the dyspeptic patients

From: Characteristics of gastric precancerous conditions and Helicobacter pylori infection among dyspeptic patients in north-eastern Iran: is endoscopic biopsy and histopathological assessment necessary?

Categorical variable

Precancerous conditions (n = 585)

P-value

Abnormal gastric biopsy (n = 585)

P-value

Atrophy (n = 585)

P-value

Metaplasia (n = 585)

P-value

Dysplasia (n = 585)

P-value

Yes (n = 122)

No (n = 463)

Yes (n = 103)

No (n = 482)

Yes (n = 74)

No (n = 511)

Yes (n = 89)

No (n = 496)

Yes (n = 46)

No (n = 539)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

Age (years)

  < = 40

7 (5.7)

208 (44.9)

0.001

59 (57.3)

156 (32.4)

0.001

2 (2.7)

213 (41.7)

0.001

5 (5.6)

210 (42.3)

0.001

2 (4.3)

213 (39.5)

0.001

 41–50

33 (27.1)

91 (19.7)

16 (15.5)

107 (22.4)

13 (17.6)

111 (21.7)

19 (21.3)

105 (21.2)

16 (34.8)

108 (20.0)

 51–60

34 (27.9)

89 (19.2)

16 (15.5)

108 (22.2)

22 (29.7)

101 (19.8)

24 (27.0)

99 (20.0)

9 (19.6)

114 (21.2)

  > = 61

48 (39.3)

75 (16.2)

12 (11.7)

111 (23.0)

37 (50.0)

86 (16.8)

41 (46.1)

82 (16.5)

19 (41.3)

104 (19.3)

Sex

 Female (n = 397)

76 (62.3)

321 (69.3)

0.15

78 (75.7)

319 (66.2)

0.06

41 (55.4)

356 (69.7)

0.01

52 (58.4)

345 (69.6)

0.04

32 (69.6)

365 (67.7)

0.79

 Male (n = 188)

46 (37.7)

142 (30.7)

25 (24.3)

163 (33.8)

33 (44.6)

155 (30.3)

37 (41.6)

151 (30.4)

14 (30.4)

174 (32.3)

Smoking

 Yes (n = 112)

25 (20.5)

87 (18.8)

0.69

16 (15.5)

96 (19.9)

0.38

17 (23.0)

95 (18.6)

0.37

20 (22.5)

92 (18.5)

0.39

9 (19.6)

103 (19.1)

0.94

 No (n = 473)

97 (79.5)

376 (81.2)

87 (84.5)

386 (80.1)

57 (77.0)

416 (81.4)

69 (77.5)

404 (81.5)

37 (80.4)

436 (80.9)

Addiction*

 Yes (n = 146)

43 (35.2)

103 (22.2)

0.003

19 (18.4)

127 (26.3)

0.09

30 (40.5)

116 (22.7)

0.001

35 (39.3)

111 (22.4)

0.001

17 (36.9)

129 (23.9)

0.05

 No (n = 439)

79 (64.8)

360 (77.8)

84 (81.6)

355 (73.7)

44 (59.5)

395 (77.3)

54 (60.7)

385 (77.6)

29 (63.1)

410 (76.1)

Alcohol consumption

 Yes (n = 50)

11 (9.0)

39 (8.4)

0.85

8 (7.8)

42 (8.7)

0.85

6 (8.1)

44 (8.6)

0.88

6 (6.7)

44 (8.9)

0.86

3 (6.5)

47 (8.7)

0.78

 No (n = 535)

111 (81.0)

424 (91.6)

95 (92.2)

440 (91.3)

68 (91.9)

467 (91.4)

83 (93.3)

452 (91.1)

43 (93.5)

492 (91.3)

NSAID use

 Yes (n = 173)

18 (14.7)

155 (33.5)

0.001

27 (26.2)

146 (30.3)

0.47

11 (14.9)

162 (31.7)

0.003

13 (14.6)

160 (32.3)

0.001

6 (13.0)

167 (31.0)

0.01

 No (n = 412)

104 (85.3)

308 (66.5)

76 (73.8)

336 (69.7)

63 (85.1)

349 (68.3)

76 (85.4)

336 (67.7)

46 (87.0)

372 (69.0)

Aspirin use

 Yes (n = 88)

15 (12.3)

73 (15.8)

0.39

15 (14.6)

73 (15.1)

1.0

13 (17.6)

75 (14.7)

0.51

8 (9.0)

80 (16.1)

0.08

6 (13.0)

82 (15.2)

0.69

 No (n = 497)

107 (87.7)

390 (84.2)

88 (85.4)

409 (84.9)

61 (82.4)

436 (85.3)

81 (91.0)

416 (83.9)

40 (87.0)

457 (84.8)

Diabetes (types I and II)

 Yes (n = 99)

20 (16.4)

79 (17.1)

1.0

13 (12.6)

86 (17.8)

0.25

15 (20.3)

84 (16.4)

0.41

18 (20.2)

81 (16.3)

0.37

6 (13.0)

93 (17.3)

0.46

 No (n = 486)

102 (83.6)

384 (82.9)

90 (87.4)

396 (82.2)

59 (79.7)

427 (83.6)

71 (79.8)

415 (83.7)

40 (87.0)

446 (82.7)

H. pylori infection

 Yes (n = 469)

114 (93.4)

355 (76.7)

0.001

52 (50.5)

417 (86.5)

0.001

68 (91.9)

401 (78.5)

0.007

83 (93.3)

383 (77.8)

0.001

42 (91.3)

427 (79.2)

0.048

 No (n = 116)

8 (6.6)

108 (23.3)

51 (49.5)

65 (13.5)

6 (8.1)

110 (21.5)

6 (6.7)

110 (22.2)

4 (8.7)

112 (20.8)

Dyspepsia pattern

 EPS (n = 245)

50 (41.0)

195 (42.1)

0.99

46 (44.7)

199 (41.3)

0.45

31 (41.9)

214 (41.9)

0.99

37 (41.6)

208 (41.9)

0.99

17 (37.0)

228 (42.3)

0.46

 Flatulence (n = 143)

30 (24.6)

113 (24.4)

20 (19.4)

123 (25.5)

18 (24.3)

125 (24.5)

22 (24.7)

121 (24.4)

9 (19.6)

134 (24.9)

 Early satiation (n = 48)

11 (9.0)

37 (8.0)

6 (5.8)

42 (8.7)

7 (9.5)

41 (8.0)

7 (7.9)

41 (8.3)

6 (13.0)

42 (7.8)

 PF (n = 48)

10 (8.2)

38 (8.2)

9 (8.2)

39 (8.2)

6 (8.1)

42 (8.2)

8 (9.0)

40 (8.1)

6 (13.0)

42 (7.8)

 Reflux (n = 101)

21 (17.2)

80 (17.3)

22 (21.4)

79 (16.4)

12 (16.2)

89 (17.4)

15 (16.9)

86 (17.3)

8 (17.4)

93 (17.3)

Endoscopic findings

 Normal (n = 121)

5 (4.1)

116 (25.0)

0.001

5 (4.1)

116 (25.0)

0.001

2 (2.7)

119 (23.3)

0.001

5 (5.6)

116 (23.4)

0.001

2 (4.3)

119 (22.1)

0.001

 Erythema (n = 176)

23 (18.8)

153 (33.1)

23 (18.8)

153 (33.1)

10 (13.5)

166 (32.5)

12 (13.5)

164 (33.1)

12 (26.1)

164 (30.4)

 M o/s (n = 151)

33 (27.1)

118 (25.5)

33 (27.1)

118 (25.5)

18 (24.3)

133 (26.0)

20 (22.5)

131 (26.4)

12 (26.1)

139 (25.8)

 Erosion (n = 68)

18 (14.7)

50 (10.8)

18 (14.7)

50 (10.8)

11 (14.9)

57 (11.2)

17 (19.1)

51 (10.3)

6 (13.0)

62 (11.5)

 GDU (n = 36)

21 (17.2)

15 (3.2)

21 (17.2)

15 (3.2)

12 (16.2)

24 (4.7)

16 (18.0)

20 (4.0)

7 (15.2)

29 (5.4)

 Atrophy (n = 33)

22 (18.1)

11 (2.4)

22 (18.1)

11 (2.4)

21 (28.4)

12 (2.3)

19 (21.3)

14 (2.8)

7 (15.2)

26 (4.8)

FHGC

 None (n = 397)

89 (73.0)

308 (66.5)

0.77

75 (72.8)

322 (66.8)

0.012

50 (67.6)

347 (67.9)

0.87

61 (68.5)

336 (67.7)

0.98

38 (82.6)

359 (66.6)

0.53

 GC (n = 69)

12 (9.9)

57 (12.3)

13 (12.6)

56 (11.6)

7 (9.5)

62 (12.1)

11 (12.4)

58 (11.7)

3 (6.5)

66 (12.2)

 IC (n = 1)

0 (0.0)

1 (0.2)

1 (1.0)

0 (0.0)

0 (0.0)

1 (0.2)

0 (0.0)

1 (0.2)

0 (0.0)

1 (0.2)

 CC (n = 81)

17 (13.9)

64 (13.8)

5 (4.9)

76 (15.8)

14 (18.9)

67 (13.1)

13 (14.6)

68 (13.7)

4 (8.7)

77 (14.3)

 OC (n = 12)

2 (1.6)

10 (2.2)

2 (1.9)

10 (2.1)

1 (1.4)

11 (2.2)

2 (2.2)

10 (2.0)

0 (0.0)

12 (2.2)

 LC (n = 14)

1 (0.8)

13 (2.8)

4 (3.9)

10 (2.1)

1 (1.4)

13 (2.5)

1 (1.1)

13 (2.6)

1 (2.2)

13 (2.4)

 PC (n = 11)

1 (0.8)

10 (2.2)

3 (2.9)

8 (1.7)

1 (1.4)

10 (2.0)

1 (1.1)

10 (2.0)

0 (0.0)

11 (2.0)

FHNGC

 None (n = 504)

112 (91.8)

392 (84.7)

0.12

81 (78.6)

423 (87.8)

0.04

66 (89.2)

438 (85.7)

0.15

81 (91.0)

423 (85.3)

0.15

42 (91.3)

462 (85.7)

0.64

 Breast (n = 34)

2 (1.6)

32 (6.9)

8 (7.8)

26 (5.4)

1 (1.4)

33 (6.5)

1 (1.1)

33 (6.7)

2 (4.3)

32 (5.9)

 Cervical (n = 6)

1 (0.8)

5 (1.1)

2 (1.9)

4 (0.8)

1 (1.4)

5 (1.0)

1 (1.1)

5 (1.0)

0 (0.0)

6 (1.1)

 Ovarian (n = 6)

2 (1.6)

4 (0.9)

2 (1.9)

4 (0.8)

2 (2.7)

4 (0.8)

2 (2.2)

4 (0.8)

1 (2.2)

5 (0.9)

 Bladder (n = 4)

1 (0.8)

3 (0.6)

2 (1.9)

2 (0.4)

1 (1.4)

3 (0.6)

1 (1.1)

3 (0.6)

0 (0.0)

4 (0.7)

 Kidney (n = 6)

1 (0.8)

4 (0.9)

3 (2.9)

2 (0.4)

1 (1.4)

4 (0.8)

0 (0.0)

5 (1.0)

1 (2.2)

4 (0.7)

 Haematological (n = 12)

0 (0.0)

12 (2.6)

2 (1.9)

10 (2.1)

0 (0.0)

12 (2.3)

0 (0.0)

12 (2.4)

0 (0.0)

12 (2.2)

 Pulmonary (n = 14)

3 (2.5)

11 (2.4)

3 (2.9)

11 (2.3)

2 (2.7)

12 (2.3)

3 (3.4)

11 (2.2)

0 (0.0)

14 (2.6)

Continuous variable

mean ± SD

mean ± SD

P-value

mean ± SD

mean ± SD

P-value

mean ± SD

mean ± SD

P-value

mean ± SD

mean ± SD

P-value

mean ± SD

mean ± SD

P-value

Age (years)

57.8 ± 13.1

45.4 ± 13.7

0.001

41.6 ± 12.6

49.3 ± 14.5

0.001

61.0 ± 12.6

46.1 ± 13.7

0.001

59.4 ± 13.2

45.9 ± 13.7

0.001

58.6 ± 14.3

47.1 ± 14.1

0.001

Haemoglobin (Hgb)

13.3 ± 1.6

13.3 ± 1.5

0.48

13.4 ± 1.5

13.3 ± 1.5

0.62

12.9 ± 1.5

13.4 ± 1.5

0.14

13.1 ± 1.6

13.4 ± 1.5

0.12

13.4 ± 1.6

13.3 ± 1.5

0.48

25(OH)D3 vitamin

21.7 ± 13.0

18.1 ± 11.2

0.002

18.0 ± 11.5

19.0 ± 11.7

0.27

20.8 ± 12.4

18.5 ± 11.6

0.14

22.3 ± 13.7

18.2 ± 11.2

0.004

21.9 ± 11.2

18.6 ± 11.7

0.013

  1. EPS Epigastric pain syndrome; M o/s Mucosal oedema/swelling; PF Postprandial fullness; GDU Gastric or duodenal ulcer; FHGC Family history of gastro-intestinal cancer; FHNGC Family history of non-gastro/intestinal cancer; GC gastric cancer; IC Intestinal cancer; CC Colon cancer; OC Oesophagus cancer; LC Liver cancer; PC Pancreas cancer. *Addiction = opium and/or methamphetamine